OrganiGramOrganiGram Holdings Inc. (NYSE: OGI) is a cannabis company specializing in the production and retail of medical and legal-use marijuana in Canada.

While stock growth over the last year is less than impressive, shares have picked up momentum this week. Looking at the last five days of trading, the price has grown by 10.42%. This is linked to overall positivity in the market following a blowout fiscal report from Canopy Growth last Friday. Canopy is one of the largest cannabis companies in North America. OrganiGram has a direct connection to Canopy through a two-year supply and distribution agreement.

Although overall market positivity is largely linked to Canopy’s performance, OrganiGram also has its own positives to consider. In the previous quarter, it reported revenue growth of 55%, along with positive EBITDA of $4.9 million CAD. Both the growth and profitability outperformed the wider cannabis market.

OrganiGram has the potential to expand and fund its operations, thanks to $34.1 million in cash and equivalents, as well as a $30 million term loan that it is yet to utilize. A bottom end bargain price and increased confidence in the cannabis market make this an alternative stock to consider in February.

Key Data:

  • 1 Year Price Growth: -55.31%
  • YTD Price Growth: 16%
  • 3 Month Price Growth: -7.34%

All information is based on current and historical market data, as well as publicly available financial data. As with any financial decision, your own research is important. Stock market outcomes can never be 100% accurately predicted. Familiarity with historical data, individual industries, and individual stocks is key to developing a robust portfolio. Note that stock prices can fluctuate rapidly during trading sessions.